HRT Financial’s bioAffinity Technologies BIAF Stock Holding History

HRT Financial’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-628	Closed	-$4K	–	2623
2025 Q1	$4K	Buy	+628	New	+$11.5K	﹤0.01%	2410

Other funds holding BIAF

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

HRT Financial's BIAF Position: Q2 2025 in Review

HRT Financial sold out of bioAffinity Technologies (BIAF) in Q2 2025, closing a stake of 628 shares — an estimated $4K sold.

HRT Financial first reported a position in BIAF in Q1 2025 and held it in 1 quarter. The position peaked at $4K in Q1 2025. 17 funds tracked by Wall St. Rank hold BIAF as of Q2 2025.

HRT Financial reported no remaining bioAffinity Technologies position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 628 bioAffinity Technologies shares in Q2 2025, an estimated $4K.
HRT Financial first reported a position in bioAffinity Technologies in Q1 2025 and held it in 1 quarter.
HRT Financial's bioAffinity Technologies position peaked at $4K in Q1 2025.
17 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.